Phase III trial of Bharat Biotech’s COVID-19 nasal vaccine completed, may be launched soon

Paris: Bharat Biotech Chairman and Managing Director Krishna Ella said on Saturday that the Phase III trial of the COVID-19 nasal vaccine has been completed and the company will submit its data to the Drugs Controller General of India (DCGI) next month. In an exclusive interview, Dr. Ella said, “We